TERBINAFINE HYDROCHLORIDE TABLET

TERBINAFINE HYDROCHLORIDE TABLET was reported 7254 times

TERBINAFINE HYDROCHLORIDE TABLET is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CARD9 DEFICIENCY 4 1.0000
1 PYTHIUM INSIDIOSUM INFECTION 5 0.5000
2 ABSCESS SWEAT GLAND 6 0.1333
3 SOMATIC DELUSION 26 0.1057
4 FLUOROSIS 8 0.0930
5 SCEDOSPORIUM INFECTION 61 0.0864
6 DIAPHRAGMATIC SPASM 12 0.0811
7 MYCOTIC ENDOPHTHALMITIS 15 0.0794
8 CHROMOBLASTOMYCOSIS 6 0.0706
9 SEPTAL PANNICULITIS 5 0.0625
10 TRICHOPHYTOSIS 12 0.0566
11 TINEA CAPITIS 6 0.0522
12 RASH PAPULOSQUAMOUS 7 0.0464
13 SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 76 0.0427
14 INTRAOCULAR PRESSURE TEST 10 0.0417
15 ERYTHEMA ANNULARE 12 0.0414
16 SUBCORNEAL PUSTULAR DERMATOSIS 5 0.0403
17 GENERALISED PUSTULAR PSORIASIS 11 0.0379
18 RESPIRATORY GAS EXCHANGE DISORDER 14 0.0377
19 ABSCESS FUNGAL 6 0.0343
20 DERMATOPHYTOSIS 9 0.0317
21 NAIL HYPERTROPHY 6 0.0296
22 BODY TINEA 16 0.0286
23 FUSARIUM INFECTION 19 0.0271
24 FAECAL VOLUME DECREASED 13 0.0271
25 EYE INFECTION FUNGAL 10 0.0258
26 PERIOSTITIS 11 0.0255
27 PROSTATIC HAEMORRHAGE 8 0.0251
28 VANCOMYCIN INFUSION REACTION 9 0.0239
29 URTICARIAL VASCULITIS 12 0.0227
30 DERMOID CYST 7 0.0210
31 SEVERE CUTANEOUS ADVERSE REACTION 5 0.0209
32 BENIGN HEPATIC NEOPLASM 4 0.0198
33 NAIL DYSTROPHY 11 0.0196
34 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 152 0.0195
35 SOLAR DERMATITIS 5 0.0185
36 SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA 15 0.0182
37 PROCTECTOMY 5 0.0182
38 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 15 0.0178
39 PATHOGEN RESISTANCE 161 0.0176
40 CHOLURIA 6 0.0176
41 GENE MUTATION IDENTIFICATION TEST POSITIVE 7 0.0166
42 ONYCHOMYCOSIS 73 0.0166
43 FUNGAL ENDOCARDITIS 5 0.0166
44 PITYRIASIS ROSEA 6 0.0161
45 ANTIPHOSPHOLIPID ANTIBODIES POSITIVE 9 0.0155
46 OESOPHAGEAL IRRITATION 9 0.0155
47 CHLOASMA 7 0.0151
48 SYSTEMIC LUPUS ERYTHEMATOSUS RASH 12 0.0150
49 ILEOSTOMY CLOSURE 5 0.0149
50 DISSEMINATED ASPERGILLOSIS 7 0.0148
51 GIARDIASIS 5 0.0147
52 TINEA INFECTION 16 0.0145
53 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 15 0.0141
54 POLYSEROSITIS 6 0.0141
55 GLIOSIS 6 0.0140
56 TINEA VERSICOLOUR 5 0.0139
57 SYSTEMIC MYCOSIS 16 0.0137
58 IMPETIGO 20 0.0134
59 BONE METABOLISM DISORDER 4 0.0133
60 FUNGAEMIA 20 0.0127
61 CARDIAC VALVE VEGETATION 6 0.0123
62 CUTANEOUS LUPUS ERYTHEMATOSUS 23 0.0118
63 FUNGAL FOOT INFECTION 5 0.0114
64 CEREBRAL ASPERGILLOSIS 7 0.0114
65 OVARIAN FAILURE 6 0.0112
66 AGEUSIA 278 0.0111
67 MEAN CELL VOLUME ABNORMAL 5 0.0106
68 PSEUDOMONAL BACTERAEMIA 9 0.0105
69 PHAEOHYPHOMYCOSIS 5 0.0104
70 CHRONIC SPONTANEOUS URTICARIA 12 0.0103
71 LENTIGO 5 0.0101
72 ELECTROCARDIOGRAM QT INTERVAL ABNORMAL 5 0.0100
73 FAECES PALE 21 0.0094
74 CHOLESTATIC LIVER INJURY 21 0.0094
75 FUNGAL SKIN INFECTION 38 0.0094
76 PUSTULE 22 0.0093
77 INTERTRIGO 5 0.0092
78 SEBORRHOEIC DERMATITIS 15 0.0091
79 XEROSIS 11 0.0089
80 TINEA PEDIS 14 0.0088
81 PUSTULAR PSORIASIS 28 0.0081
82 HYPERPARATHYROIDISM SECONDARY 20 0.0080
83 DRUG RESISTANCE 205 0.0080
84 INTESTINAL ANASTOMOSIS 5 0.0078
85 MUCOSAL EROSION 7 0.0077
86 NAIL INFECTION 11 0.0077
87 PREMATURE MENOPAUSE 7 0.0076
88 RASH PUSTULAR 55 0.0075
89 ERYTHRODERMIC PSORIASIS 6 0.0073
90 POUCHITIS 6 0.0070
91 ANOGENITAL WARTS 6 0.0067
92 SALIVA ALTERED 6 0.0067
93 NEUROPSYCHIATRIC SYMPTOMS 6 0.0066
94 TEMPORAL ARTERITIS 6 0.0065
95 MYASTHENIC SYNDROME 5 0.0065
96 NEPHROGENIC ANAEMIA 29 0.0063
97 ONYCHALGIA 6 0.0060
98 ERYTHEMA NODOSUM 21 0.0060
99 REBOUND ACID HYPERSECRETION 18 0.0059
100 VITREOUS OPACITIES 5 0.0059
101 DERMATITIS EXFOLIATIVE GENERALISED 20 0.0057
102 SOMATIC SYMPTOM DISORDER 6 0.0056
103 PRODUCT SELECTION ERROR 6 0.0055
104 CHOLANGITIS ACUTE 4 0.0053
105 PROTHROMBIN TIME SHORTENED 7 0.0050
106 HEPATITIS TOXIC 13 0.0050
107 BALANOPOSTHITIS 4 0.0049
108 GASTROINTESTINAL MOTILITY DISORDER 26 0.0049
109 NORMOCYTIC ANAEMIA 7 0.0048
110 BONE DEMINERALISATION 5 0.0047
111 BILIARY OBSTRUCTION 6 0.0046
112 ARRHYTHMIA SUPRAVENTRICULAR 5 0.0046
113 ERYTHEMA MULTIFORME 41 0.0044
114 AORTIC STENOSIS 15 0.0043
115 SKIN PLAQUE 36 0.0043
116 URINE ODOUR ABNORMAL 25 0.0042
117 NEUTROPHILIA 24 0.0042
118 RECTAL TENESMUS 5 0.0040
119 THROMBOTIC THROMBOCYTOPENIC PURPURA 14 0.0040
120 MACULE 11 0.0040
121 ABNORMAL LOSS OF WEIGHT 27 0.0040
122 VENOUS THROMBOSIS LIMB 8 0.0039
123 LATENT TUBERCULOSIS 8 0.0038
124 NAIL DISCOLOURATION 15 0.0038
125 ANTIPHOSPHOLIPID SYNDROME 6 0.0037
126 VULVOVAGINAL CANDIDIASIS 5 0.0037
127 BILE DUCT OBSTRUCTION 7 0.0037
128 APLASTIC ANAEMIA 19 0.0036
129 LINEAR IGA DISEASE 6 0.0036
130 DIABETIC METABOLIC DECOMPENSATION 5 0.0036
131 DERMATITIS EXFOLIATIVE 18 0.0036
132 DERMATITIS BULLOUS 26 0.0036
133 VASCULAR PURPURA 5 0.0036
134 ANAL HAEMORRHAGE 10 0.0036
135 PERIORBITAL OEDEMA 18 0.0035
136 HAEMANGIOMA 8 0.0035
137 SEBORRHOEIC KERATOSIS 5 0.0034
138 HYPERSENSITIVITY VASCULITIS 9 0.0034
139 DERMATITIS PSORIASIFORM 7 0.0034
140 LUPUS-LIKE SYNDROME 31 0.0034
141 BILIARY DILATATION 5 0.0034
142 PRURITUS GENITAL 8 0.0034
143 DRUG-INDUCED LIVER INJURY 105 0.0033
144 INFECTIOUS PLEURAL EFFUSION 5 0.0033
145 PHOTOSENSITIVITY REACTION 54 0.0033
146 MYELITIS 5 0.0032
147 ONYCHOLYSIS 5 0.0032
148 TOXIC SKIN ERUPTION 32 0.0032
149 BRAIN ABSCESS 8 0.0032
150 THROMBOPHLEBITIS 11 0.0031
151 PAPULE 22 0.0031
152 ABDOMINAL WALL HAEMATOMA 6 0.0031
153 ABNORMAL FAECES 25 0.0030
154 ASPERGILLUS INFECTION 20 0.0030
155 CUTANEOUS VASCULITIS 11 0.0030
156 HEPATIC LESION 13 0.0030
157 ROSACEA 14 0.0030
158 HEPATORENAL SYNDROME 5 0.0030
159 FOOD AVERSION 5 0.0029
160 OTORRHOEA 5 0.0029
161 CHROMATURIA 64 0.0028
162 JAUNDICE CHOLESTATIC 10 0.0028
163 FORCED EXPIRATORY VOLUME DECREASED 8 0.0028
164 HEPATITIS CHOLESTATIC 17 0.0028
165 RENAL TUBULAR ACIDOSIS 6 0.0027
166 HENOCH-SCHONLEIN PURPURA 6 0.0027
167 EXFOLIATIVE RASH 7 0.0027
168 HYPERCOAGULATION 5 0.0026
169 CHRONIC KIDNEY DISEASE 199 0.0026
170 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 23 0.0026
171 GAMBLING DISORDER 7 0.0026
172 LICHEN PLANUS 6 0.0026
173 ANHEDONIA 68 0.0026
174 SKIN WARM 15 0.0026
175 END STAGE RENAL DISEASE 47 0.0026
176 SWELLING OF EYELID 16 0.0025
177 LIVER FUNCTION TEST ABNORMAL 74 0.0025
178 DRUG LEVEL BELOW THERAPEUTIC 14 0.0025
179 JAUNDICE 68 0.0025
180 LIP SWELLING 84 0.0025
181 CHOLESTASIS 48 0.0025
182 ANTINUCLEAR ANTIBODY POSITIVE 8 0.0025
183 EYELID PAIN 5 0.0025
184 ORAL DISCOMFORT 34 0.0024
185 ANOSMIA 35 0.0024
186 CONTRAINDICATED PRODUCT PRESCRIBED 4 0.0024
187 TONGUE ULCERATION 8 0.0024
188 TONGUE DISCOMFORT 10 0.0024
189 DYSGEUSIA 175 0.0024
190 HEPATOSPLENOMEGALY 6 0.0023
191 ENDOPHTHALMITIS 14 0.0023
192 WOUND COMPLICATION 8 0.0023
193 CARDIAC TAMPONADE 11 0.0023
194 MUCORMYCOSIS 6 0.0023
195 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 17 0.0023
196 SKIN LESION 62 0.0023
197 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 6 0.0023
198 MOUTH SWELLING 13 0.0023
199 RASH MACULO-PAPULAR 49 0.0022
200 FUNGAL INFECTION 73 0.0022
201 SKIN EROSION 7 0.0022
202 ALCOHOL USE 8 0.0022
203 LUNG CONSOLIDATION 6 0.0021
204 ECONOMIC PROBLEM 32 0.0021
205 PURULENT DISCHARGE 9 0.0021
206 RASH ERYTHEMATOUS 100 0.0021
207 SUBCUTANEOUS ABSCESS 10 0.0021
208 COMA SCALE ABNORMAL 6 0.0021
209 BICYTOPENIA 4 0.0020
210 HEPATIC FIBROSIS 7 0.0020
211 CHEILITIS 11 0.0020
212 PNEUMONIA FUNGAL 8 0.0020
213 DEPRESSION SUICIDAL 7 0.0020
214 JAW DISORDER 11 0.0020
215 DERMATITIS 42 0.0020
216 MIXED LIVER INJURY 6 0.0020
217 EMBOLISM VENOUS 6 0.0020
218 INTERNATIONAL NORMALISED RATIO DECREASED 8 0.0020
219 ILEOSTOMY 5 0.0020
220 ANAL PRURITUS 4 0.0019
221 ACTINIC KERATOSIS 5 0.0019
222 POSTMENOPAUSAL HAEMORRHAGE 5 0.0019
223 ATRIAL SEPTAL DEFECT 16 0.0019
224 PSYCHIATRIC SYMPTOM 14 0.0019
225 STEVENS-JOHNSON SYNDROME 42 0.0019
226 GINGIVAL PAIN 15 0.0019
227 SINUS BRADYCARDIA 18 0.0019
228 TREATMENT FAILURE 154 0.0019
229 GINGIVITIS 10 0.0019
230 TOXIC EPIDERMAL NECROLYSIS 28 0.0018
231 LIP BLISTER 5 0.0018
232 DERMATITIS ALLERGIC 23 0.0018
233 MELANOCYTIC NAEVUS 8 0.0018
234 ASTHENOPIA 10 0.0018
235 HYPERKERATOSIS 10 0.0018
236 DRUG ERUPTION 32 0.0018
237 BACTERIAL TEST POSITIVE 4 0.0018
238 B-CELL LYMPHOMA 6 0.0018
239 HEPATOCELLULAR INJURY 25 0.0018
240 SKIN HYPERPIGMENTATION 15 0.0017
241 PNEUMONIA BACTERIAL 16 0.0017
242 RASH GENERALISED 45 0.0017
243 POLYURIA 14 0.0017
244 TOOTH DISCOLOURATION 5 0.0017
245 BREATH ODOUR 4 0.0016
246 FOOD INTOLERANCE 6 0.0016
247 RENAL TUBULAR NECROSIS 16 0.0016
248 PARADOXICAL DRUG REACTION 6 0.0016
249 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 4 0.0016
250 SKIN EXFOLIATION 135 0.0016
251 LIVER INJURY 39 0.0016
252 CHOLECYSTITIS ACUTE 9 0.0016
253 SPUTUM DISCOLOURED 15 0.0016
254 OSTEOPENIA 24 0.0016
255 FORMICATION 11 0.0016
256 RASH MACULAR 55 0.0016
257 ACUTE HEPATIC FAILURE 21 0.0015
258 DEAFNESS NEUROSENSORY 5 0.0015
259 ISCHAEMIC STROKE 27 0.0015
260 SWOLLEN TONGUE 47 0.0015
261 NEPHROPATHY 14 0.0015
262 SALIVARY HYPERSECRETION 15 0.0015
263 QUALITY OF LIFE DECREASED 20 0.0015
264 SQUAMOUS CELL CARCINOMA OF SKIN 9 0.0015
265 MICTURITION URGENCY 17 0.0015
266 BRUXISM 8 0.0015
267 CANDIDA INFECTION 25 0.0015
268 TASTE DISORDER 30 0.0015
269 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 38 0.0015
270 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 8 0.0015
271 DRUG INTERACTION 233 0.0015
272 PAROSMIA 11 0.0015
273 RENAL INJURY 43 0.0014
274 HYPERTRANSAMINASAEMIA 10 0.0014
275 AUTOIMMUNE HEPATITIS 10 0.0014
276 HEART RATE ABNORMAL 8 0.0014
277 LEUKOCYTOSIS 25 0.0014
278 ATRIAL FLUTTER 11 0.0014
279 BLISTER 76 0.0014
280 CYTOMEGALOVIRUS VIRAEMIA 6 0.0013
281 OBSTRUCTIVE AIRWAYS DISORDER 15 0.0013
282 TENDON INJURY 5 0.0013
283 SKIN INFECTION 15 0.0013
284 PANCREATITIS ACUTE 30 0.0013
285 VITAMIN D DEFICIENCY 13 0.0013
286 MOUTH ULCERATION 28 0.0013
287 HEPATOMEGALY 13 0.0013
288 DERMATITIS CONTACT 15 0.0013
289 ANAL ABSCESS 7 0.0013
290 APHTHOUS ULCER 10 0.0013
291 NORMAL NEWBORN 7 0.0013
292 EPIGASTRIC DISCOMFORT 5 0.0013
293 MUSCULOSKELETAL DISCOMFORT 22 0.0013
294 OESOPHAGEAL PAIN 5 0.0013
295 RED BLOOD CELL COUNT DECREASED 36 0.0013
296 PULMONARY ALVEOLAR HAEMORRHAGE 7 0.0012
297 SKIN PAPILLOMA 5 0.0012
298 ACUTE KIDNEY INJURY 190 0.0012
299 COLECTOMY 7 0.0012
300 AGRANULOCYTOSIS 23 0.0012
301 MAJOR DEPRESSION 9 0.0012
302 HEPATITIS ACUTE 8 0.0012
303 PHARYNGEAL SWELLING 12 0.0012
304 GOITRE 5 0.0012
305 HYPERVOLAEMIA 6 0.0012
306 SOCIAL AVOIDANT BEHAVIOUR 7 0.0012
307 ABDOMINAL TENDERNESS 6 0.0012
308 HYPERAMMONAEMIA 6 0.0012
309 CONGESTIVE CARDIOMYOPATHY 5 0.0012
310 ONYCHOMADESIS 5 0.0012
311 FACE OEDEMA 20 0.0012
312 HEPATIC CYTOLYSIS 15 0.0012
313 ABSCESS LIMB 5 0.0012
314 ONYCHOCLASIS 8 0.0012
315 RASH PAPULAR 26 0.0012
316 ALTERED STATE OF CONSCIOUSNESS 25 0.0012
317 OCULAR ICTERUS 5 0.0012
318 BONE DENSITY DECREASED 36 0.0011
319 DIVERTICULUM INTESTINAL 5 0.0011
320 SERUM FERRITIN INCREASED 6 0.0011
321 DEVICE OCCLUSION 16 0.0011
322 GINGIVAL SWELLING 5 0.0011
323 MULTIPLE ORGAN DYSFUNCTION SYNDROME 32 0.0011
324 RHABDOMYOLYSIS 47 0.0011
325 OBSESSIVE-COMPULSIVE DISORDER 9 0.0011
326 DECREASED ACTIVITY 12 0.0011
327 RASH PRURITIC 60 0.0011
328 RENAL FAILURE 146 0.0011
329 DRUG LEVEL ABOVE THERAPEUTIC 5 0.0011
330 ERECTILE DYSFUNCTION 28 0.0011
331 EAR INFECTION 29 0.0011
332 RENAL IMPAIRMENT 90 0.0011
333 PETECHIAE 11 0.0011
334 CHOLECYSTITIS CHRONIC 7 0.0010
335 INCONTINENCE 11 0.0010
336 HEPATOTOXICITY 23 0.0010
337 EOSINOPHILIA 18 0.0010
338 DEPRESSED MOOD 54 0.0010
339 URTICARIA 171 0.0010
340 LARGE INTESTINE POLYP 7 0.0010
341 INFLAMMATORY MARKER INCREASED 5 0.0010
342 FLUID INTAKE REDUCED 5 0.0010
343 BLEPHARITIS 4 0.0010
344 PNEUMOCYSTIS JIROVECII PNEUMONIA 10 0.0010
345 HYPOAESTHESIA ORAL 15 0.0010
346 ORAL PAIN 22 0.0010
347 BODY TEMPERATURE INCREASED 20 0.0010
348 DRUG ABUSER 6 0.0010
349 HAEMORRHOIDS 19 0.0010
350 TENDON RUPTURE 12 0.0010
351 SKIN NECROSIS 5 0.0010
352 LYMPHADENOPATHY 34 0.0010
353 EPSTEIN-BARR VIRUS INFECTION 6 0.0010
354 RESTLESSNESS 35 0.0010
355 SWELLING FACE 62 0.0010
356 POLYARTHRITIS 5 0.0009
357 HYPOPHOSPHATAEMIA 7 0.0009
358 EYELID OEDEMA 11 0.0009
359 RASH 411 0.0009
360 BONE LOSS 14 0.0009
361 URINARY RETENTION 31 0.0009
362 PSORIASIS 121 0.0009
363 ANGINA UNSTABLE 6 0.0009
364 SKIN LACERATION 10 0.0009
365 DEAFNESS 24 0.0009
366 HYPERTHERMIA 7 0.0009
367 HYPOGAMMAGLOBULINAEMIA 6 0.0009
368 MANIA 15 0.0009
369 ORAL CANDIDIASIS 12 0.0009
370 HEPATIC ENZYME INCREASED 62 0.0009
371 TUBULOINTERSTITIAL NEPHRITIS 17 0.0009
372 BRONCHOPULMONARY ASPERGILLOSIS 7 0.0009
373 INTRACRANIAL PRESSURE INCREASED 5 0.0009
374 HEMIPARESIS 15 0.0009
375 LIVER FUNCTION TEST INCREASED 19 0.0009
376 GENERALISED ERYTHEMA 5 0.0009
377 HIDRADENITIS 8 0.0009
378 SCAB 10 0.0009
379 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 48 0.0009
380 SKIN ATROPHY 5 0.0009
381 DROOLING 6 0.0009
382 PRURITUS 333 0.0009
383 ARTHRITIS INFECTIVE 4 0.0009
384 PERSONALITY CHANGE 8 0.0009
385 APHASIA 26 0.0009
386 ECZEMA 45 0.0009
387 HEPATITIS 22 0.0009
388 ANGIOEDEMA 38 0.0009
389 BLOOD COUNT ABNORMAL 13 0.0009
390 PERIPHERAL SWELLING 132 0.0009
391 PERIPHERAL SENSORY NEUROPATHY 5 0.0009
392 ANAPHYLACTIC SHOCK 22 0.0009
393 DISCOMFORT 52 0.0009
394 SKIN REACTION 12 0.0009
395 DRUG DISPENSING ERROR 13 0.0008
396 BRADYKINESIA 5 0.0008
397 SPINAL COMPRESSION FRACTURE 7 0.0008
398 NEUTROPENIC SEPSIS 6 0.0008
399 EOSINOPHIL COUNT INCREASED 7 0.0008
400 HEARING IMPAIRED 5 0.0008
401 THERAPY PARTIAL RESPONDER 13 0.0008
402 OSTEOPOROSIS 34 0.0008
403 DIZZINESS POSTURAL 8 0.0008
404 TENSION 5 0.0008
405 TOOTH LOSS 17 0.0008
406 VITAMIN D DECREASED 7 0.0008
407 PAIN OF SKIN 22 0.0008
408 GLOMERULAR FILTRATION RATE DECREASED 10 0.0008
409 TINNITUS 37 0.0008
410 PEMPHIGOID 6 0.0008
411 MULTIPLE FRACTURES 13 0.0008
412 PRODUCT USE IN UNAPPROVED INDICATION 196 0.0008
413 DIABETES MELLITUS INADEQUATE CONTROL 14 0.0008
414 FEELING COLD 22 0.0008
415 LETHARGY 45 0.0008
416 THERAPY NON-RESPONDER 35 0.0008
417 LOSS OF LIBIDO 7 0.0008
418 OCCUPATIONAL EXPOSURE TO PRODUCT 5 0.0008
419 INTERVERTEBRAL DISC PROTRUSION 17 0.0008
420 PROCTALGIA 5 0.0008
421 LIMB DISCOMFORT 24 0.0008
422 HYPERBILIRUBINAEMIA 8 0.0008
423 C-REACTIVE PROTEIN INCREASED 28 0.0008
424 PANCYTOPENIA 43 0.0008
425 TENDERNESS 8 0.0008
426 BRAIN FOG 12 0.0008
427 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 13 0.0008
428 BLOOD ALKALINE PHOSPHATASE INCREASED 19 0.0008
429 PRODUCT ADMINISTRATION INTERRUPTED 6 0.0008
430 SYSTEMIC LUPUS ERYTHEMATOSUS 27 0.0008
431 HALLUCINATION, VISUAL 16 0.0008
432 HEPATIC FUNCTION ABNORMAL 28 0.0007
433 ARTHRITIS 59 0.0007
434 SKIN MASS 5 0.0007
435 NASAL CONGESTION 44 0.0007
436 MENINGITIS 5 0.0007
437 DEPRESSION 170 0.0007
438 ANAL FISSURE 4 0.0007
439 SENSORY LOSS 6 0.0007
440 LOCAL SWELLING 13 0.0007
441 DECREASED APPETITE 172 0.0007
442 POSTOPERATIVE WOUND INFECTION 5 0.0007
443 AKATHISIA 10 0.0007
444 HICCUPS 6 0.0007
445 HYPERAESTHESIA 6 0.0007
446 MUSCLE INJURY 6 0.0007
447 ANXIETY 205 0.0007
448 EPILEPSY 22 0.0007
449 EMOTIONAL DISTRESS 87 0.0007
450 INFLAMMATION 37 0.0007
451 ERYTHEMA 147 0.0007
452 HYPOPHAGIA 18 0.0007
453 MYOCARDITIS 8 0.0007
454 PARANOIA 12 0.0007
455 PANIC REACTION 5 0.0007
456 ENCEPHALOPATHY 17 0.0007
457 SKIN SWELLING 6 0.0007
458 SCIATICA 11 0.0007
459 SKIN DISORDER 23 0.0007
460 TOOTH ABSCESS 7 0.0007
461 FRACTURE 13 0.0007
462 VASCULITIS 8 0.0007
463 EXTRAPYRAMIDAL DISORDER 17 0.0007
464 SPINAL OSTEOARTHRITIS 6 0.0007
465 WOUND 19 0.0007
466 PURPURA 6 0.0007
467 NEUTROPENIA 92 0.0007
468 DISEASE PROGRESSION 80 0.0007
469 VENTRICULAR EXTRASYSTOLES 7 0.0007
470 EYE SWELLING 25 0.0007
471 GASTROINTESTINAL INFECTION 6 0.0007
472 GOUT 12 0.0007
473 MYOSITIS 6 0.0007
474 CONDITION AGGRAVATED 203 0.0007
475 FOLLICULITIS 7 0.0007
476 MEDICATION ERROR 37 0.0007
477 SKIN FISSURES 13 0.0007
478 NIGHTMARE 23 0.0007
479 DRUG LEVEL INCREASED 11 0.0007
480 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 47 0.0007
481 IMPAIRED GASTRIC EMPTYING 9 0.0007
482 BREAST PAIN 7 0.0007
483 BURNING SENSATION 46 0.0007
484 SUICIDAL IDEATION 60 0.0007
485 GENERALISED OEDEMA 8 0.0006
486 PHARYNGITIS 8 0.0006
487 ILEUS 8 0.0006
488 SEPTIC SHOCK 28 0.0006
489 PEMPHIGUS 8 0.0006
490 GASTROINTESTINAL INFLAMMATION 5 0.0006
491 MYALGIA 108 0.0006
492 DENTAL CARIES 7 0.0006
493 INTERNATIONAL NORMALISED RATIO INCREASED 18 0.0006
494 RESPIRATORY FAILURE 46 0.0006
495 DISEASE RECURRENCE 30 0.0006
496 DERMATITIS ATOPIC 33 0.0006
497 PALLOR 17 0.0006
498 MOOD ALTERED 17 0.0006
499 SENSORY DISTURBANCE 10 0.0006
500 MIOSIS 5 0.0006
501 LOCALISED INFECTION 15 0.0006
502 INFLAMMATORY BOWEL DISEASE 6 0.0006
503 BODY TEMPERATURE DECREASED 6 0.0006
504 GASTRITIS 16 0.0006
505 LIGAMENT SPRAIN 6 0.0006
506 DELIRIUM 21 0.0006
507 RESTLESS LEGS SYNDROME 11 0.0006
508 DRY MOUTH 49 0.0006
509 PANIC ATTACK 22 0.0006
510 WEIGHT DECREASED 168 0.0006
511 PRURITUS GENERALISED 13 0.0006
512 COAGULOPATHY 10 0.0006
513 FAECES DISCOLOURED 13 0.0006
514 LIVE BIRTH 5 0.0006
515 DYSURIA 22 0.0006
516 BLOOD BILIRUBIN INCREASED 16 0.0006
517 FEEDING DISORDER 12 0.0006
518 PSORIATIC ARTHROPATHY 24 0.0006
519 BLOOD CREATINE PHOSPHOKINASE INCREASED 17 0.0006
520 BONE MARROW FAILURE 12 0.0006
521 DRUG LEVEL DECREASED 6 0.0006
522 NEPHROLITHIASIS 27 0.0006
523 CHOLECYSTITIS 7 0.0006
524 EAR DISCOMFORT 6 0.0006
525 HALLUCINATION 44 0.0006
526 HYPOCALCAEMIA 11 0.0006
527 ANURIA 5 0.0006
528 INFECTION 84 0.0006
529 FOOT FRACTURE 11 0.0006
530 BLOOD URINE PRESENT 11 0.0006
531 ADRENAL INSUFFICIENCY 7 0.0006
532 CELLULITIS 29 0.0006
533 DISTURBANCE IN ATTENTION 31 0.0006
534 APHONIA 8 0.0006
535 DRUG PRESCRIBING ERROR 11 0.0006
536 RECTAL HAEMORRHAGE 24 0.0006
537 HAEMOLYTIC ANAEMIA 5 0.0006
538 PRODUCT SUBSTITUTION ISSUE 32 0.0006
539 FREQUENT BOWEL MOVEMENTS 15 0.0006
540 BIPOLAR DISORDER 6 0.0006
541 CHOLELITHIASIS 18 0.0005
542 BONE DISORDER 10 0.0005
543 EXOSTOSIS 5 0.0005
544 TOOTH FRACTURE 6 0.0005
545 GAMMA-GLUTAMYLTRANSFERASE INCREASED 12 0.0005
546 UPPER RESPIRATORY TRACT INFECTION 25 0.0005
547 INTERVERTEBRAL DISC DEGENERATION 5 0.0005
548 TACHYCARDIA 48 0.0005
549 DRUG INEFFECTIVE 712 0.0005
550 ARTHROPOD BITE 4 0.0005
551 TRANSAMINASES INCREASED 12 0.0005
552 AGGRESSION 27 0.0005
553 CONJUNCTIVITIS 10 0.0005
554 HEPATIC STEATOSIS 10 0.0005
555 ABDOMINAL DISTENSION 56 0.0005
556 GLOSSODYNIA 12 0.0005
557 OEDEMA 29 0.0005
558 ALOPECIA 105 0.0005
559 STATUS EPILEPTICUS 6 0.0005
560 ARTERIOSCLEROSIS 5 0.0005
561 IMMUNE SYSTEM DISORDER 7 0.0005
562 SQUAMOUS CELL CARCINOMA 5 0.0005
563 REBOUND EFFECT 6 0.0005
564 CEREBRAL HAEMORRHAGE 19 0.0005
565 PRODUCT DOSE OMISSION IN ERROR 15 0.0005
566 METRORRHAGIA 9 0.0005
567 HYPERSOMNIA 15 0.0005
568 BOWEL MOVEMENT IRREGULARITY 4 0.0005
569 OROPHARYNGEAL PAIN 48 0.0005
570 ANKLE FRACTURE 8 0.0005
571 NEEDLE ISSUE 15 0.0005
572 JOINT INJURY 11 0.0005
573 SPLENOMEGALY 6 0.0005
574 ASCITES 15 0.0005
575 COELIAC DISEASE 5 0.0005
576 LYMPHOCYTE COUNT DECREASED 9 0.0005
577 CYANOSIS 8 0.0005
578 MALAISE 223 0.0005
579 ABNORMAL DREAMS 14 0.0005
580 ABDOMINAL DISCOMFORT 85 0.0005
581 DYSARTHRIA 19 0.0005
582 DISORIENTATION 20 0.0005
583 HYPERHIDROSIS 65 0.0005
584 GALLBLADDER DISORDER 9 0.0005
585 PRODUCT PRESCRIBING ERROR 12 0.0005
586 ABDOMINAL PAIN 117 0.0005
587 HAEMATURIA 17 0.0005
588 PARAESTHESIA 78 0.0005
589 LYMPHOPENIA 7 0.0005
590 SCHIZOPHRENIA 6 0.0005
591 SINUS TACHYCARDIA 7 0.0005
592 BLOOD POTASSIUM INCREASED 8 0.0005
593 EYELID PTOSIS 5 0.0005
594 BACK DISORDER 8 0.0005
595 SLUGGISHNESS 5 0.0005
596 RESPIRATORY DEPRESSION 6 0.0005
597 HAEMATOCHEZIA 27 0.0005
598 PARALYSIS 7 0.0005
599 PARAESTHESIA ORAL 7 0.0005
600 VENTRICULAR TACHYCARDIA 8 0.0005
601 POOR VENOUS ACCESS 5 0.0005
602 SWELLING 45 0.0005
603 ABNORMAL BEHAVIOUR 19 0.0005
604 MUSCULOSKELETAL STIFFNESS 42 0.0005
605 HYPONATRAEMIA 27 0.0005
606 PHOTOPHOBIA 9 0.0005
607 VERTIGO 29 0.0005
608 SCRATCH 5 0.0005
609 FULL BLOOD COUNT ABNORMAL 5 0.0005
610 ATRIAL FIBRILLATION 46 0.0005
611 PULMONARY MASS 7 0.0005
612 CIRCULATORY COLLAPSE 8 0.0005
613 GASTROINTESTINAL HAEMORRHAGE 39 0.0005
614 PYREXIA 161 0.0005
615 POOR QUALITY SLEEP 10 0.0005
616 DYSPHAGIA 44 0.0005
617 VAGINAL HAEMORRHAGE 20 0.0005
618 ORTHOSTATIC HYPOTENSION 8 0.0005
619 PRODUCT PRESCRIBING ISSUE 10 0.0005
620 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 22 0.0005
621 INSURANCE ISSUE 7 0.0005
622 MUSCULAR WEAKNESS 52 0.0005
623 FEELING HOT 28 0.0005
624 ASPIRATION 5 0.0005
625 THROMBOCYTOPENIA 51 0.0005
626 TOOTH INFECTION 6 0.0005
627 PHARYNGEAL OEDEMA 7 0.0005
628 DEVICE RELATED INFECTION 7 0.0005
629 ACTIVITIES OF DAILY LIVING IMPAIRED 9 0.0005
630 PANCREATITIS 24 0.0005
631 ABDOMINAL PAIN UPPER 93 0.0005
632 CONFUSIONAL STATE 73 0.0005
633 LIVER DISORDER 20 0.0005
634 PAIN 277 0.0005
635 GENERAL PHYSICAL HEALTH DETERIORATION 52 0.0004
636 HYPERTENSIVE CRISIS 5 0.0004
637 GASTROOESOPHAGEAL REFLUX DISEASE 36 0.0004
638 EYE PRURITUS 15 0.0004
639 ARTHRALGIA 185 0.0004
640 WHITE BLOOD CELL COUNT DECREASED 48 0.0004
641 PNEUMONIA ASPIRATION 11 0.0004
642 ALANINE AMINOTRANSFERASE INCREASED 27 0.0004
643 ABSCESS 7 0.0004
644 RIB FRACTURE 9 0.0004
645 PROSTATIC SPECIFIC ANTIGEN INCREASED 6 0.0004
646 CHILLS 51 0.0004
647 ASPARTATE AMINOTRANSFERASE INCREASED 23 0.0004
648 LACTIC ACIDOSIS 14 0.0004
649 MUSCLE TIGHTNESS 7 0.0004
650 POLLAKIURIA 18 0.0004
651 HEPATIC FAILURE 13 0.0004
652 HYPOMAGNESAEMIA 6 0.0004
653 THERAPEUTIC RESPONSE DECREASED 26 0.0004
654 APPENDICITIS 4 0.0004
655 HYPERKALAEMIA 15 0.0004
656 PLEURAL EFFUSION 26 0.0004
657 OSTEOARTHRITIS 18 0.0004
658 WHEEZING 25 0.0004
659 NEUROLEPTIC MALIGNANT SYNDROME 5 0.0004
660 MUSCULOSKELETAL DISORDER 8 0.0004
661 MUCOSAL INFLAMMATION 11 0.0004
662 MUSCULOSKELETAL PAIN 22 0.0004
663 SPEECH DISORDER 22 0.0004
664 LEUKOPENIA 21 0.0004
665 MYOCLONUS 5 0.0004
666 SLEEP APNOEA SYNDROME 8 0.0004
667 RHINORRHOEA 27 0.0004
668 WRIST FRACTURE 5 0.0004
669 DIABETIC KETOACIDOSIS 10 0.0004
670 ACUTE RESPIRATORY FAILURE 8 0.0004
671 TRANSIENT ISCHAEMIC ATTACK 14 0.0004
672 HYPERSENSITIVITY 77 0.0004
673 SKIN DISCOLOURATION 19 0.0004
674 FATIGUE 321 0.0004
675 NOCTURIA 5 0.0004
676 EAR PAIN 8 0.0004
677 NEURALGIA 10 0.0004
678 AUTOIMMUNE DISORDER 4 0.0004
679 NEUROPATHY PERIPHERAL 39 0.0004
680 INSOMNIA 109 0.0004
681 THERAPY CESSATION 21 0.0004
682 MULTIPLE SCLEROSIS RELAPSE 28 0.0004
683 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 7 0.0004
684 VISION BLURRED 56 0.0004
685 FEBRILE NEUTROPENIA 27 0.0004
686 MUSCLE SPASTICITY 5 0.0004
687 CHEST PAIN 75 0.0004
688 SINUS DISORDER 8 0.0004
689 MOBILITY DECREASED 29 0.0004
690 HAEMATOCRIT DECREASED 8 0.0004
691 DEEP VEIN THROMBOSIS 26 0.0004
692 FULL BLOOD COUNT DECREASED 8 0.0004
693 IMPAIRED HEALING 13 0.0004
694 OSTEONECROSIS 13 0.0004
695 EYE DISORDER 13 0.0004
696 MUSCLE ATROPHY 5 0.0004
697 HEART RATE INCREASED 39 0.0004
698 GAIT DISTURBANCE 75 0.0004
699 JOINT SWELLING 47 0.0004
700 ROTATOR CUFF SYNDROME 5 0.0004
701 RENAL DISORDER 18 0.0004
702 OEDEMA PERIPHERAL 47 0.0004
703 BASAL CELL CARCINOMA 6 0.0004
704 FLUSHING 39 0.0004
705 DIZZINESS 191 0.0004
706 BLOOD CREATININE INCREASED 25 0.0004
707 SLEEP DISORDER 27 0.0004
708 SEDATION 10 0.0004
709 AGITATION 28 0.0004
710 HEADACHE 239 0.0004
711 DRY EYE 19 0.0004
712 ASTHMA 43 0.0004
713 BLOOD LACTATE DEHYDROGENASE INCREASED 6 0.0004
714 ULCER 6 0.0004
715 DYSSTASIA 11 0.0004
716 BACTERIAL INFECTION 7 0.0004
717 BODY HEIGHT DECREASED 4 0.0004
718 NAUSEA 296 0.0004
719 LOWER RESPIRATORY TRACT INFECTION 17 0.0004
720 BLOOD PRESSURE INCREASED 57 0.0004
721 PSYCHOTIC DISORDER 11 0.0004
722 NIGHT SWEATS 12 0.0004
723 SKIN CANCER 8 0.0004
724 PAIN IN EXTREMITY 109 0.0004
725 THROAT TIGHTNESS 10 0.0004
726 GASTROINTESTINAL DISORDER 33 0.0004
727 FEELING JITTERY 7 0.0004
728 DRY SKIN 49 0.0004
729 COUGH 102 0.0004
730 APPLICATION SITE RASH 5 0.0004
731 CONTRAINDICATED PRODUCT ADMINISTERED 11 0.0004
732 STOMATITIS 22 0.0004
733 PSYCHOMOTOR HYPERACTIVITY 6 0.0004
734 DIVERTICULITIS 10 0.0004
735 CHOKING 7 0.0004
736 SEPSIS 40 0.0004
737 BONE PAIN 21 0.0004
738 BLOOD UREA INCREASED 6 0.0004
739 DIARRHOEA 231 0.0004
740 DEMENTIA 10 0.0004
741 MASS 5 0.0004
742 KIDNEY INFECTION 7 0.0004
743 SNEEZING 8 0.0004
744 DISSEMINATED INTRAVASCULAR COAGULATION 5 0.0004
745 HEART RATE IRREGULAR 8 0.0004
746 RENAL FAILURE ACUTE 15 0.0004
747 INTENTIONAL DOSE OMISSION 10 0.0004
748 INFLUENZA 39 0.0003
749 MUSCLE SPASMS 64 0.0003
750 BACK PAIN 81 0.0003
751 HERPES ZOSTER 20 0.0003
752 SHOCK 8 0.0003
753 DIPLOPIA 9 0.0003
754 DYSPNOEA 196 0.0003
755 ASTHENIA 130 0.0003
756 DYSPEPSIA 34 0.0003
757 CYSTITIS 11 0.0003
758 DYSPNOEA EXERTIONAL 13 0.0003
759 MOOD SWINGS 11 0.0003
760 HYPOKINESIA 5 0.0003
761 NEUTROPHIL COUNT DECREASED 14 0.0003
762 AMENORRHOEA 6 0.0003
763 PALPITATIONS 40 0.0003
764 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 10 0.0003
765 HYPOXIA 12 0.0003
766 ACUTE MYOCARDIAL INFARCTION 10 0.0003
767 LABORATORY TEST ABNORMAL 10 0.0003
768 PERITONITIS 7 0.0003
769 DRUG EFFECT LESS THAN EXPECTED 5 0.0003
770 SKIN HAEMORRHAGE 5 0.0003
771 BACTERAEMIA 4 0.0003
772 ATAXIA 4 0.0003
773 SKIN BURNING SENSATION 24 0.0003
774 URINARY TRACT INFECTION 57 0.0003
775 GASTROENTERITIS VIRAL 6 0.0003
776 TOOTHACHE 6 0.0003
777 LIMB INJURY 9 0.0003
778 ACNE 25 0.0003
779 BURSITIS 4 0.0003
780 OFF LABEL USE 287 0.0003
781 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 6 0.0003
782 MENTAL STATUS CHANGES 9 0.0003
783 ABNORMAL WEIGHT GAIN 4 0.0003
784 TENDONITIS 5 0.0003
785 VISUAL IMPAIRMENT 40 0.0003
786 DELUSION 5 0.0003
787 PRODUCT DOSE OMISSION 21 0.0003
788 HYPOAESTHESIA 48 0.0003
789 LOSS OF CONSCIOUSNESS 41 0.0003
790 SYNCOPE 32 0.0003
791 APPLICATION SITE PAIN 7 0.0003
792 COLITIS 12 0.0003
793 INFLUENZA LIKE ILLNESS 26 0.0003
794 PROTEINURIA 6 0.0003
795 CARDIOVASCULAR DISORDER 8 0.0003
796 TOOTH DISORDER 7 0.0003
797 MIGRAINE 30 0.0003
798 OBESITY 5 0.0003
799 INJURY 22 0.0003
800 METABOLIC ACIDOSIS 10 0.0003
801 BALANCE DISORDER 27 0.0003
802 THERAPEUTIC RESPONSE UNEXPECTED 14 0.0003
803 ADVERSE DRUG REACTION 28 0.0003
804 BRONCHITIS 23 0.0003
805 NASOPHARYNGITIS 57 0.0003
806 PNEUMONIA 100 0.0003
807 ORAL HERPES 6 0.0003
808 ELECTROCARDIOGRAM QT PROLONGED 11 0.0003
809 HYPOKALAEMIA 14 0.0003
810 CRYING 11 0.0003
811 CATARACT 18 0.0003
812 HYPOACUSIS 13 0.0003
813 BLOOD PRESSURE ABNORMAL 6 0.0003
814 TREMOR 50 0.0003
815 CONTUSION 29 0.0003
816 COGNITIVE DISORDER 14 0.0003
817 GAIT INABILITY 10 0.0003
818 LACRIMATION INCREASED 9 0.0003
819 FEAR 8 0.0003
820 ANGER 10 0.0003
821 DRUG ADMINISTRATION ERROR 9 0.0003
822 SCAR 5 0.0003
823 HOT FLUSH 22 0.0003
824 BLOOD PRESSURE FLUCTUATION 7 0.0003
825 ANAPHYLACTIC REACTION 16 0.0003
826 HYPOGLYCAEMIA 14 0.0003
827 HYPERTENSION 61 0.0003
828 WHITE BLOOD CELL COUNT INCREASED 11 0.0003
829 CARPAL TUNNEL SYNDROME 4 0.0003
830 OXYGEN SATURATION DECREASED 16 0.0003
831 BLOOD TEST ABNORMAL 4 0.0003
832 CONSTIPATION 62 0.0003
833 FALL 94 0.0003
834 BRONCHOSPASM 4 0.0003
835 BLOOD CHOLESTEROL INCREASED 13 0.0003
836 DEPRESSED LEVEL OF CONSCIOUSNESS 11 0.0003
837 HAEMATEMESIS 7 0.0003
838 ARRHYTHMIA 13 0.0003
839 APATHY 4 0.0003
840 STAPHYLOCOCCAL INFECTION 9 0.0003
841 VOMITING 128 0.0003
842 UNRESPONSIVE TO STIMULI 7 0.0003
843 DEHYDRATION 36 0.0003
844 THINKING ABNORMAL 5 0.0003
845 THROAT IRRITATION 12 0.0003
846 RESPIRATORY DISORDER 8 0.0003
847 HEPATIC CIRRHOSIS 5 0.0003
848 BLOOD SODIUM DECREASED 5 0.0003
849 DRUG INTOLERANCE 25 0.0003
850 HERNIA 5 0.0003
851 ERUCTATION 5 0.0003
852 ACUTE MYELOID LEUKAEMIA 4 0.0003
853 RHEUMATOID ARTHRITIS 29 0.0003
854 WEIGHT INCREASED 57 0.0003
855 SINUSITIS 26 0.0003
856 ARTHROPATHY 14 0.0003
857 THERAPY INTERRUPTED 18 0.0003
858 INTENTIONAL PRODUCT USE ISSUE 22 0.0003
859 MULTIPLE SCLEROSIS 12 0.0003
860 NECK PAIN 14 0.0003
861 DIABETES MELLITUS 19 0.0002
862 MOVEMENT DISORDER 8 0.0002
863 HIP FRACTURE 8 0.0002
864 INTENTIONAL SELF-INJURY 5 0.0002
865 INJECTION SITE REACTION 17 0.0002
866 EXTRA DOSE ADMINISTERED 10 0.0002
867 PRESYNCOPE 6 0.0002
868 COLITIS ULCERATIVE 11 0.0002
869 AMNESIA 16 0.0002
870 CEREBRAL INFARCTION 6 0.0002
871 CHEST DISCOMFORT 25 0.0002
872 EYE IRRITATION 14 0.0002
873 FEELING ABNORMAL 58 0.0002
874 THERAPEUTIC RESPONSE SHORTENED 8 0.0002
875 VISUAL ACUITY REDUCED 8 0.0002
876 EPISTAXIS 18 0.0002
877 COVID-19 42 0.0002
878 UNEVALUABLE EVENT 18 0.0002
879 TREATMENT NONCOMPLIANCE 13 0.0002
880 EATING DISORDER 5 0.0002
881 PRODUCT USE ISSUE 44 0.0002
882 IMPAIRED WORK ABILITY 5 0.0002
883 GASTRIC DISORDER 8 0.0002
884 ILLNESS 24 0.0002
885 MEMORY IMPAIRMENT 32 0.0002
886 SKIN ULCER 6 0.0002
887 RESPIRATORY TRACT INFECTION 6 0.0002
888 CARDIAC ARREST 19 0.0002
889 MENTAL DISORDER 10 0.0002
890 PRODUCT DISPENSING ERROR 5 0.0002
891 FLATULENCE 13 0.0002
892 CLOSTRIDIUM DIFFICILE INFECTION 5 0.0002
893 JOINT STIFFNESS 6 0.0002
894 INTENTIONAL PRODUCT MISUSE 20 0.0002
895 BLOOD TRIGLYCERIDES INCREASED 4 0.0002
896 MENSTRUATION IRREGULAR 6 0.0002
897 HAEMOGLOBIN DECREASED 23 0.0002
898 HEAD INJURY 7 0.0002
899 APPLICATION SITE PRURITUS 5 0.0002
900 DRUG EFFECT INCOMPLETE 8 0.0002
901 ADVERSE EVENT 20 0.0002
902 PROCEDURAL PAIN 6 0.0002
903 ANAEMIA 41 0.0002
904 PRODUCT DOSE OMISSION ISSUE 63 0.0002
905 EYE PAIN 12 0.0002
906 INTESTINAL OBSTRUCTION 8 0.0002
907 PAIN IN JAW 6 0.0002
908 CARDIAC FAILURE CONGESTIVE 17 0.0002
909 INFUSION RELATED REACTION 14 0.0002
910 OCULAR HYPERAEMIA 10 0.0002
911 BLOOD PRESSURE DECREASED 14 0.0002
912 NERVOUSNESS 11 0.0002
913 CONVULSION 12 0.0002
914 ANGINA PECTORIS 6 0.0002
915 FIBROMYALGIA 5 0.0002
916 SOMNOLENCE 41 0.0002
917 THERAPEUTIC PRODUCT EFFECT DECREASED 9 0.0002
918 PULMONARY EMBOLISM 19 0.0002
919 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 36 0.0002
920 HEART RATE DECREASED 7 0.0002
921 THROMBOSIS 16 0.0002
922 CORONARY ARTERY DISEASE 6 0.0002
923 ILL-DEFINED DISORDER 12 0.0002
924 HAEMATOMA 5 0.0002
925 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 10 0.0002
926 WITHDRAWAL SYNDROME 8 0.0002
927 PRODUCTIVE COUGH 9 0.0002
928 SURGERY 11 0.0002
929 SEIZURE 21 0.0002
930 RESPIRATORY DISTRESS 5 0.0002
931 TYPE 2 DIABETES MELLITUS 6 0.0002
932 TARDIVE DYSKINESIA 5 0.0002
933 FLUID RETENTION 9 0.0002
934 SKIN IRRITATION 8 0.0002
935 DYSPHONIA 10 0.0002
936 URINARY INCONTINENCE 5 0.0002
937 OVERDOSE 36 0.0002
938 TOXICITY TO VARIOUS AGENTS 28 0.0002
939 MALIGNANT NEOPLASM PROGRESSION 17 0.0002
940 EMOTIONAL DISORDER 5 0.0002
941 ABASIA 4 0.0002
942 DEVICE LEAKAGE 7 0.0002
943 HYPOTHYROIDISM 5 0.0002
944 HAEMORRHAGE 16 0.0002
945 IRRITABILITY 9 0.0001
946 PROSTATE CANCER 12 0.0001
947 DRUG EFFECT DECREASED 8 0.0001
948 MATERNAL EXPOSURE DURING PREGNANCY 13 0.0001
949 ROAD TRAFFIC ACCIDENT 6 0.0001
950 CEREBROVASCULAR ACCIDENT 24 0.0001
951 INTENTIONAL OVERDOSE 9 0.0001
952 MYOCARDIAL INFARCTION 24 0.0001
953 HYPERGLYCAEMIA 5 0.0001
954 BLOOD POTASSIUM DECREASED 4 0.0001
955 COMPLETED SUICIDE 11 0.0001
956 BRADYCARDIA 7 0.0001
957 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 9 0.0001
958 INJECTION SITE BRUISING 10 0.0001
959 LUNG DISORDER 6 0.0001
960 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 4 0.0001
961 CARDIAC DISORDER 11 0.0001
962 HYPOTENSION 23 0.0001
963 DEVICE MALFUNCTION 8 0.0001
964 PLATELET COUNT DECREASED 12 0.0001
965 PULMONARY OEDEMA 5 0.0001
966 INCORRECT DOSE ADMINISTERED 25 0.0001
967 ACCIDENTAL OVERDOSE 4 0.0001
968 DRUG DOSE OMISSION 18 0.0001
969 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 5 0.0001
970 ACCIDENTAL EXPOSURE TO PRODUCT 11 0.0001
971 COLORECTAL CANCER 5 0.0001
972 SUICIDE ATTEMPT 6 0.0001
973 INJECTION SITE ERYTHEMA 12 0.0001
974 BLOOD GLUCOSE INCREASED 18 0.0001
975 INJECTION SITE PAIN 29 0.0001
976 HOSPITALISATION 14 0.0001
977 DEATH 77 0.0001
978 PRODUCT QUALITY ISSUE 12 0.0001
979 CARDIAC FAILURE 7 0.0001
980 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 17 0.0001
981 BLOOD GLUCOSE DECREASED 4 0.0001
982 EXPOSURE DURING PREGNANCY 5 0.0001
983 INJECTION SITE SWELLING 6 0.0001
984 UNDERDOSE 5 0.0001
985 INJECTION SITE HAEMORRHAGE 5 0.0001
986 DRUG DEPENDENCE 10 0.0001
987 NO ADVERSE EVENT 11 0.0001
988 DRUG ABUSE 5 0.0001
989 DEVICE ISSUE 5 0.0001